Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

Clinical trial NCT05732831 · RECRUITING

Trial details

NCT number: NCT05732831
Sponsor: Tango Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Locally Advanced Solid Tumor

Start date: 2023-05-26
Primary completion: 2026-05-01
Enrollment: 225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.